AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia Ruchika Sharma1 Jan 2023 10:00 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.
AstraZeneca gets CDSCO panel nod to study anticancer drug Datopotamab deruxtecan Dr. Divya Colin31 Dec 2022 5:45 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January Ruchika Sharma31 Dec 2022 1:15 PM ISTTo date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer Ruchika Sharma28 Dec 2022 11:30 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
AstraZeneca Forxiga recommended for nod in EU for chronic heart failure Ruchika Sharma20 Dec 2022 5:30 PM ISTHeart failue is a life-threatening chronic disease in which the heart cannot pump enough blood around the body, affecting 15 million people in the EU.
Setback to AstraZeneca: Imfinzi fails as monotherapy for non-small lung cancer Ruchika Sharma20 Dec 2022 1:30 PM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Conduct CT in Indian population: CDSCO Panel Tells AstraZeneca for Anifrolumab Dr. Divya Colin19 Dec 2022 6:00 PM ISTNew Delhi: Highlighting that the there is no study data available in Indian population for monoclonal antibody Anifrolumab 150mg/ml concentrate for...
Experts say patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement Ruchika Sharma10 Dec 2022 1:30 PM ISTUK: The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doctors' ability to...
AstraZeneca to sell West Chester site to National Resilience Ruchika Sharma4 Dec 2022 11:00 AM ISTAstraZeneca expects to complete the sale in the first quarter of 2023, with a phased transition of services.
AstraZeneca to buy Neogene Therapeutics for over Rs 2605 crore Ruchika Sharma3 Dec 2022 12:15 PM ISTNeogene will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam, the Netherlands and California, US.
AstraZeneca enters into USD 402 million global licensing agreement with C4X Discovery Holdings Ruchika Sharma29 Nov 2022 11:00 AM ISTNRF2 is an important natural regulator, controlling the expression of antioxidant genes, and it plays a key role in cellular defense against external...
CDSCO nod to AstraZeneca Pharma Dapagliflozin tablets Ruchika Sharma28 Nov 2022 4:30 PM ISTThe receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded...
